Design and development of a soluble PDA-Emodin-PVP-MN patch and its anti-obesity effect in rats-Reference-Cited by-同舟云学术

Design and development of a soluble PDA-Emodin-PVP-MN patch and its anti-obesity effect in rats

Published:2024-05-22 Issue: Volume: Page:
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Wang Haijiao,Wang Lifang,Wang Meng,Niu Jingjing,Yang Bowen,Wang Yinxiong,An Min,Sun Xiuxia,Yang Zhigang,Li Xuefeng,Shi Yanbin^ORCID

Funder

Technology Innovation Guide Project of Gansu Province, China

Lanzhou University Innovation and Entrepreneurship Cultivation Program, China

Cultivation Project of Medical Student Innovation and Entrepreneurship Competition of Lanzhou University Medical Science Department, China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13346-024-01623-9.pdf

Reference42 articles.

1. Dangol M, Kim S, Li CG, Fakhraei Lahiji S, Jang M, Ma Y, Huh I, Jung H. Anti-obesity effect of a novel caffeine-loaded dissolving microneedle patch in high-fat diet-induced obese C57BL/6J mice. J Control Release. 2017;265:41–7. https://doi.org/10.1016/j.jconrel.2017.03.400.

2. Sibuyi NRS, Moabelo KL, Meyer M, Onani MO, Dube A, Madiehe AM. Nanotechnology advances towards development of targeted-treatment for obesity. J Nanobiotechnol. 2019;17:122. https://doi.org/10.1186/s12951-019-0554-3.

3. Pagotto U, Vanuzzo D, Vicennati V, Pasquali R. Pharmacological therapy of obesity. G Ital Cardiol (Rome) 2008;9:83S-93S. https://pubmed.ncbi.nlm.nih.gov/18773755/.

4. Goodarzi G, Tehrani SS, Panahi G, Bahramzadeh A, Meshkani R. Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and non-alcoholic fatty liver disease in high-fat diet obese C57BL/6 mice. J Nutr Biochem. 2023;118:109369. https://doi.org/10.1016/j.jnutbio.2023.109369.

5. Hinney A, Körner A, Fischer-Posovszky P. The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits. Nat Rev Endocrinol. 2022;18:623–37. https://doi.org/10.1038/s41574-022-00716-0.